The Business of Fashion
Agenda-setting intelligence, analysis and advice for the global fashion community.
Agenda-setting intelligence, analysis and advice for the global fashion community.
LAVAL, Canada — Valeant Pharmaceuticals International Inc. agreed to sell three skincare brands to L'Oréal SA for $1.3 billion in the second asset sale announced Tuesday by the struggling Canadian drugmaker as it seeks to cut its debt load.
The three brands — CeraVe, AcneFree and Ambi — have combined annual sales of about $168 million, Paris-based L'Oréal said in a statement. The company said the products will become part of its Active Cosmetics Division, which includes brands such as La Roche-Posay, Vichy and SkinCeuticals.
Earlier Tuesday, Valeant agreed to sell its Dendreon Pharmaceuticals unit to China's Sanpower Group Co. for about $820 million. The Laval, Quebec-based company has been embroiled in scandals about its high prices and accounting that led to legal and regulatory investigations along with declines in its share price.
By Phil Serafino; editors: Benedikt Kammel and David Whitehouse.
Related Articles:
[ L’Oreal to Acquire IT Cosmetics for $1.2 Billion in CashOpens in new window ]
Brands say they’re barreling ahead with marketing and commerce on the app, even as the clock starts ticking for owner ByteDance to sell it or shut it down.
The Spanish beauty and fashion conglomerate’s smart acquisitions and diverse portfolio could be a big draw for investors. Plus, Adidas is set to confirm its stellar first quarter.
How not to look tired? Make money.
In a rare video this week, the mega-singer responded to sceptics and gave the public a look at what her beauty founder personality might be.